Sruthi Ranganathan

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Sruthi Ranganathan

Dec 5, 2024, 15:21 | Insight

Timothée Olivier: NATALEE trial - 3 years of adjuvant ribociclib in early breast cancer

Timothée Olivier, Medical oncologist at the Oncology Division of Geneva University, shared on X: "NATALEE trial:…

Aug 19, 2024, 07:46 | Insight

Aakash Desai: A must-read for those interested in the cutting-edge advancements in Oncology and Cancer Research

Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared a post by…

Jul 5, 2024, 06:31 | Blog

Timothée Olivier: CDK4/6 inhibitors as adjuvant therapy in ER+ /HER2- early breast cancer

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X: "Our…

May 5, 2024, 07:48 | Blog

Timothée Olivier: The regulatory failure of sotorasib in lung!

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals shared a thread on X:…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023